Temozolomide Capsules, 250 mg, 5-count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown,...

FDA Recall #D-0444-2017 — Class II — December 20, 2016

Recall #D-0444-2017 Date: December 20, 2016 Classification: Class II Status: Terminated

Product Description

Temozolomide Capsules, 250 mg, 5-count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA, NDC 0378-5265-98.

Reason for Recall

Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.

Recalling Firm

Mylan LLC. — Caguas, PR

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

588 bottles

Distribution

Nationwide in the USA

Code Information

LOT #: 2006912, Exp 02/18

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated